Renalytix Plc (RNLX)
NASDAQ: RNLX · Real-Time Price · USD
0.291
-0.004 (-1.29%)
At close: Sep 18, 2024, 4:00 PM
0.286
-0.005 (-1.79%)
After-hours: Sep 18, 2024, 7:24 PM EDT
Renalytix Market Cap
Renalytix has a market cap or net worth of $20.82 million as of September 18, 2024. Its market cap has decreased by -81.06% in one year.
Market Cap
20.82M
Enterprise Value
25.75M
1-Year Change
-81.06%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since July 17, 2020, Renalytix's market cap has decreased from $475.30M to $20.82M, a decrease of -95.62%. That is a compound annual growth rate of -52.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2024 | 22.40M | 17.89% |
| Dec 29, 2023 | 19.00M | -72.86% |
| Dec 30, 2022 | 70.00M | -87.81% |
| Dec 31, 2021 | 574.30M | -0.33% |
| Dec 31, 2020 | 576.20M | 21.23% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pieris Pharmaceuticals | 21.92M |
| Spectral AI | 21.83M |
| Vincerx Pharma | 21.61M |
| NeurAxis | 21.55M |
| Brainstorm Cell Therapeutics | 21.21M |
| Minerva Neurosciences | 20.46M |
| SeaStar Medical Holding | 20.41M |
| MEI Pharma | 20.32M |